Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Finasteride may cause long-lasting sexual side effects.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Lowering testosterone speeds up wound healing in male mice.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Minoxidil and finasteride effectively treat hair loss.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Aromatase gene variation may increase female hair loss risk.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Minoxidil works better than nitroglycerin for treating impotence with fewer side effects.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Prolactin affects when mice shed and grow hair.